Filing Details
- Accession Number:
- 0001991925-23-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-11 17:08:11
- Reporting Period:
- 2023-09-07
- Accepted Time:
- 2023-09-11 17:08:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1173281 | Neubase Therapeutics Inc. | NBSE | Pharmaceutical Preparations (2834) | 465622433 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1991925 | Symetryx Corp | 2828 Bathurst St #400 Toronto A6 M6B3A7 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Disposition | 2023-09-07 | 74,852 | $1.80 | 605,149 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Disposition | 2023-09-08 | 128,847 | $1.53 | 476,302 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Disposition | 2023-09-11 | 3,376 | $1.44 | 472,926 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Of the 472,926 shares listed on Table I in Column 5 as beneficially owned by Symetryx Corporation prior to filing this Form 4: Symetryx Corporation beneficially owns 282,445 shares; Barry Shiff, an individual through his retirement accounts, beneficially owns 109,508 shares; and Aleta Shiff, an individual through her retirement accounts, beneficially owns 80,973 shares. As reported on the Schedule 13D dated August 30, 2023, these three shareholders may be deemed to beneficially own the shares of common stock beneficially owned by each other.
Billionaire Hedge Funds
